MondayApr 19, 2021 11:15 am

New Discovery May Redeem Cancer Immunotherapies That Failed During Clinical Trials

A new study conducted by researchers from the University of Virginia Cancer Center may be the key to better immunotherapies for the treatment of solid tumors caused by triple-negative breast cancer, colon cancer and ovarian cancer; these cancers were found to be effective in lab tests but failed in human clinical trials. In the study, the researchers explained how antibody approaches were effective in killing cancer tumors when lab tests were conducted but were ineffective in patients. Jogender Tushir-Singh of the Department of Biochemistry and Molecular Genetics, UVA School of Medicine, explained that the team’s findings showed that the approaches…

Continue Reading

MondayApr 19, 2021 11:00 am

Healthy Extracts Inc. (HYEX) Reinforces its Foothold in the Broader Wellness Industry

Plant-based supplements gaining popularity for treating chronic cardiovascular and neuro ailments Healthy Extracts, Inc. intensifies its foothold through its subsidiaries BergaMet North America and Ultimate Brain Nutrients The company recently announced positive results of clinical studies for two leading products, BergaMet North America’s HERHEART(TM) and UBN’s Fuel4Thought(TM) Brain Booster Plant-based diets (“PBD”) decrease the serum levels of inflammation by reducing levels of ROS (https://ibn.fm/tA2MU). Also, chronic neuropathic pain is a common debilitating problem and its treatment presents a major challenge to health care. Studies indicate that plants and some constituents of herbal medicine have the potential to cure neuropathic pain…

Continue Reading

FridayApr 16, 2021 12:15 pm

Largely Untapped Market for Hallucinogenic Draws Attention of Researchers at XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT)

XPhyto Therapeutics Corp., a life sciences technology accelerator, is looking for ways to turn promising psychedelics into therapeutic pharmaceutical drugs, and recently added mescaline to its study profile Mescaline is illegal under U.S. federal law, but some state-centric efforts to legalize or decriminalize the hallucinogenic have launched in a manner similar to the populace effort that produced a wave of cannabis product legalization Mescaline has historically defied predictable outcomes by researchers, but advocates cite it as a means of successfully treating some mental health and substance abuse disorders A number of psychedelics production stocks saw huge gains during the past…

Continue Reading

FridayApr 16, 2021 11:40 am

New Study Suggests That Where You Live May Influence Reproductive Health

A recent study conducted by University of Nottingham researchers suggests that the environment in which men inhabit could impact their reproductive health. The study, which was reported in “Scientific Reports,” examined the impact of geographical location on chemicals discovered in testes of dogs. Some of these chemicals have been found to influence reproductive health. The study centered on dogs because they are common pets and are usually exposed to the same chemicals used in the house as their owners because they live in the same environment. The group of researchers also searched for any signs of abnormalities in the dogs’…

Continue Reading

ThursdayApr 15, 2021 3:18 pm

Researchers Discover Children with Down Syndrome Face Higher Risk of Leukemia

A large-scale study conducted by researchers from UC San Francisco and UC Davis Health has found that Down syndrome is a high-risk factor for childhood leukemia. The study, which evaluated the leukemia risk in children suffering from Down syndrome, was reported in the “Journal of Pediatrics.” It found a strong link between acute myeloid leukemia, which is a type of blood cancer, and Down syndrome. Down syndrome, among the most prevalent genetic conditions in Canada and the United States, affects roughly 6,000 infants born annually in the two countries. That equates to roughly one in every 750 babies born in…

Continue Reading

WednesdayApr 14, 2021 1:35 pm

Study Finds That Sugar Compromises Brain Development in Children

A recent study conducted by a faculty member from the University of Georgia, in partnership with a team of researchers from the University of Southern California, has found that the daily consumption of beverages sweetened with sugar during adolescence damages performance on a memory and learning task during adulthood. The group of researchers demonstrated that changes in the bacteria found in the gut could be the key to the memory impairment caused by sugar. High-sugar diets have also been associated with health effects such as heart disease and obesity as well as impaired memory function. The research, published in “Translational…

Continue Reading

TuesdayApr 13, 2021 2:15 pm

Researchers Find New Way to Categorize COVID-19 Patients

A new study conducted by researchers from the University of Minnesota Medical School and their colleagues has found three phenotypes of the novel coronavirus, which demonstrate distinct characteristics as well as different clinical outcomes, complications and comorbidities in patient populations. The three COVID-19 phenotypes were discussed in detail in the researchers’ study, which was reported in the open-access “PLOS ONE” journal. The coronavirus has infected more than 18 million individuals as well as led to the death of more than 700,000 people across the globe. The disease’s presentation varies considerably, which suggests that not only do distinct clinical phenotypes exist,…

Continue Reading

TuesdayApr 13, 2021 1:31 pm

Real-World Evidence and Market Access Symposium Features Timely Advisement During COVID Era

Organized by Dynamic Global Events (“DGE”), a market research and event outreach organization with experience in relevant B2B life science conferences Taking place April 14-15 with an online, live-streamed format Experts from some two dozen organizations and companies addressing timely real-world evidence (“RWE”) applicable to the COVID-19 pandemic’s disruptive effect on societies A potential tool for preparing to transform regulatory submissions, clinical decision making and value demonstrations Dynamic Global Events (“DGE”) will leverage its extensive market research, targeted outreach and content-driven team’s experience to deliver the latest in a series of relevant B2B events within the life sciences arena, focusing…

Continue Reading

MondayApr 12, 2021 3:01 pm

Nonhospitalized Long-Haul Coronavirus Patients Susceptible to Cognitive Dysfunction

A group of researchers from the Feinberg School of Medicine at Northwestern University has discovered additional evidence of cognitive dysfunction in many coronavirus patients who were not hospitalized after contracting the infection. The group’s findings were reported in the “Annals of Clinical and Translational Neurology” journal. In the study, the researchers looked into medical data of nonhospitalized coronavirus patients from 21 different states who were experiencing long-term symptoms of the coronavirus, documenting what they discovered from the study. As the pandemic surges on, despite measures to contain it, media outlets have continued to report statistics on the number of mortalities…

Continue Reading

MondayApr 12, 2021 1:01 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Files First Order for Rapid COVID Test Kits Amid European Regulatory Approval

Bioscience technology accelerator XPhyto Therapeutics Corp. recently announced it had placed its first order for its Covid-ID Lab rapid, portable virus test from its German development partner XPhyto received approval for the test kit last month from European regulators with oversight of in vitro diagnostic device (CE-IVD) use certification and the internationally agreed-on ISO 13485 medical product quality standards The Covid-ID Lab is designed to help beleaguered industries and government regulators quickly screen for the COVID-19 virus at point-of-care sites, and the company expects to begin sales and distribution in April XPhyto has just completed a rebranding effort that includes…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000